⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLMD News
Relmada Therapeutics, Inc. Common Stock
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
RLMD
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
globenewswire.com
RLMD
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
globenewswire.com
RLMD
From gut to brain: NUS scientists engineer bacteria to treat severe liver-related brain dysfunction
prnewswire.com
RLMD
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director Ready to Announce with Confidence?
newsfilecorp.com
RLMD
JNJ
Form 8-K
sec.gov
RLMD